Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee

February 12, 2019: Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee

https://www.fda.gov/AdvisoryCommittees/Calendar/ucm630167.htm

Source: FDA Center for Drug Evaluation and Research - What's New - January 30, 2019 Category: Drugs & Pharmacology Source Type: news

More News: Drugs & Pharmacology | Pancreatic Cancer